Resveratrol improves ovariectomy and chronic restraint stress-induced depression-like behaviors in mice through brain-derived neurotrophic factor associated structural synaptic remodeling
- Hui Xu 1,2, Zhen-Qiang Zhang 2, Geng Chen 2, Ming-Jun Ge 2, Zong-Hao Yu 2, Jun-Xian Shen 2, Chuan Pan 2, Fei Han 2, Xiu-Ling Zhu 2,3, Ya-Ping Lu 2
- Hui Xu 1,2, Zhen-Qiang Zhang 2, Geng Chen 2
- 1Department of Basic Medicine, Anhui College of Traditional Chinese Medicine.
- 2College of Life Science, Anhui Normal University.
- 3Department of Anatomy, Wannan Medical College, Wuhu, China.
- 0Department of Basic Medicine, Anhui College of Traditional Chinese Medicine.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Resveratrol demonstrates antidepressant effects in menopausal depression models by enhancing synaptic plasticity. It upregulates brain-derived neurotrophic factor (BDNF) and increases dendritic spine density in key brain regions.
Area Of Science
- Neuroscience
- Pharmacology
- Endocrinology
Background
- Menopausal depression lacks clear treatment mechanisms.
- Resveratrol shows antidepressant potential in various models.
- The specific effects of resveratrol on menopausal depression are not well understood.
Purpose Of The Study
- To investigate the antidepressant effects of resveratrol in a menopausal depression model.
- To elucidate the underlying mechanisms involving synaptic plasticity in the hippocampus and medial prefrontal cortex (mPFC).
Main Methods
- Established a menopausal depression model in ovariectomized transgenic mice with chronic restraint stress.
- Assessed antidepressant effects using behavioral tests (TST, FST, SPT, NSFT).
- Evaluated dendritic and dendritic spine density, and quantified BDNF, cofilin1, and p-cofilin1 levels via imaging and molecular analysis.
Main Results
- Resveratrol significantly reduced immobility in TST and NSFT, and increased sucrose consumption in SPT.
- Resveratrol treatment increased the density of p-cofilin1 immunoreactive dendritic spines.
- Resveratrol upregulated brain-derived neurotrophic factor (BDNF) mRNA levels in the hippocampus and mPFC.
Conclusions
- Resveratrol improves menopausal depression-like behaviors.
- The mechanism involves enhanced synaptic plasticity through BDNF upregulation and increased dendritic spine density.
- Resveratrol shows promise for treating menopausal depression.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

